Skip to main content
Equibles
ACET logo

ACET · Adicet Bio, Inc. · Investor Relations

Track ACET — free

Use ACET with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ACET.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.52 -0.01 (-0.22%)
Rebalance outlook locked
Market Cap
$43.34M
Shares
9.36M
Volume · Oct 20 126.52K Avg daily vol (3M) 186.43K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-09-30 Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) Event
2026-09-28 Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis Event
2026-09-25 Adicet Bio to Host Webcast to Present Prula-cel (formerly ADI-001) Clinical Data in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis Webcast
2026-09-02 Adicet Bio to Participate in Fireside Chat at H.C. Wainwright 28th Annual Global Investment Conference Conference
2026-09-01 Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provides Corporate Update Event
2026-08-31 Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) Event
2026-08-27 Adicet Bio Announces FDA Clearance of IND Application for ADI-212 Event
2026-08-11 Canaccord Genuity 46th Annual Growth Conference Conference
2026-08-05 Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates Results publication
2026-07-21 Adicet Bio to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference Conference
2026-06-04 Jefferies Global Healthcare Conference in New York Conference
2026-05-14 Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference Conference
2026-05-13 Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates Results publication
2026-02-12 Guggenheim Emerging Outlook: Biotech Summit 2026 Event

Source: https://investor.adicetbio.com/

Key facts CIK 1720580 CUSIP 007002207 13F (30d) 3 filings 3 filers Visit website Investor relations